texto impreso

Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin-Mono-Resistant Pulmonary Tuberculosis in Lima, Peru

Villegas, Leonela ; Otero, Larissa ; Sterling, Timothy-R. ; Huaman, Moises-A. ; Van-der-Stuyft, Patrick ; Gotuzzo, Eduardo ; Seas, Carlos | Public Library of Science | 2019-02-06T14:48:07Z

BACKGROUND: Isoniazid and rifampicin are the two most efficacious first-line agents for tuberculosis (TB) treatment. We assessed the prevalence of isoniazid and rifampicin mono-resistance, associated risk factors, and the association of mono-res[...]

Más información...

Añadir a la cesta

Ningún comentario para este registro.

En línea: